Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895480687> ?p ?o ?g. }
- W2895480687 endingPage "235" @default.
- W2895480687 startingPage "218" @default.
- W2895480687 abstract "Structural genomic abnormalities, including balanced chromosomal rearrangements, copy number gains and losses and copy-neutral loss-of-heterozygosity (CN-LOH) represent an important category of diagnostic, prognostic and therapeutic markers in acute myeloid leukemia (AML). Genome-wide evaluation for copy number abnormalities (CNAs) is at present performed by karyotype analysis which has low resolution and is unobtainable in a subset of cases. Furthermore, examination for possible CN-LOH in leukemia cells is at present not routinely performed in the clinical setting. Chromosomal microarray (CMA) analysis is a widely available assay for CNAs and CN-LOH in diagnostic laboratories, but there are currently no guidelines how to best incorporate this technology into clinical testing algorithms for neoplastic diseases including AML. The Cancer Genomics Consortium Working Group for Myeloid Neoplasms performed an extensive review of peer-reviewed publications focused on CMA analysis in AML. Here we summarize evidence regarding clinical utility of CMA analysis in AML extracted from published data, and provide recommendations for optimal utilization of CMA testing in the diagnostic workup. In addition, we provide a list of CNAs and CN-LOH regions which have documented clinical significance in diagnosis, prognosis and treatment decisions in AML." @default.
- W2895480687 created "2018-10-12" @default.
- W2895480687 creator A5002611478 @default.
- W2895480687 creator A5005959019 @default.
- W2895480687 creator A5026614628 @default.
- W2895480687 creator A5037393607 @default.
- W2895480687 creator A5037972294 @default.
- W2895480687 creator A5038296860 @default.
- W2895480687 creator A5042991227 @default.
- W2895480687 creator A5045975673 @default.
- W2895480687 creator A5047620115 @default.
- W2895480687 creator A5058597905 @default.
- W2895480687 creator A5059373442 @default.
- W2895480687 creator A5068661649 @default.
- W2895480687 creator A5069100135 @default.
- W2895480687 creator A5073052072 @default.
- W2895480687 creator A5073322251 @default.
- W2895480687 creator A5080327876 @default.
- W2895480687 creator A5084132159 @default.
- W2895480687 creator A5089936608 @default.
- W2895480687 date "2018-12-01" @default.
- W2895480687 modified "2023-10-01" @default.
- W2895480687 title "Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group" @default.
- W2895480687 cites W1492609361 @default.
- W2895480687 cites W1514779475 @default.
- W2895480687 cites W1580450252 @default.
- W2895480687 cites W1580833069 @default.
- W2895480687 cites W1723358241 @default.
- W2895480687 cites W1739103212 @default.
- W2895480687 cites W1812256879 @default.
- W2895480687 cites W1834630892 @default.
- W2895480687 cites W1966439190 @default.
- W2895480687 cites W1969693152 @default.
- W2895480687 cites W1977052779 @default.
- W2895480687 cites W1980244567 @default.
- W2895480687 cites W1981570437 @default.
- W2895480687 cites W1984761747 @default.
- W2895480687 cites W1986715436 @default.
- W2895480687 cites W1988615111 @default.
- W2895480687 cites W1993309188 @default.
- W2895480687 cites W1994924914 @default.
- W2895480687 cites W1997412169 @default.
- W2895480687 cites W2005382317 @default.
- W2895480687 cites W2005405628 @default.
- W2895480687 cites W2005574111 @default.
- W2895480687 cites W2006254364 @default.
- W2895480687 cites W2007965628 @default.
- W2895480687 cites W2011166925 @default.
- W2895480687 cites W2012151892 @default.
- W2895480687 cites W2012945687 @default.
- W2895480687 cites W2015568081 @default.
- W2895480687 cites W2015678735 @default.
- W2895480687 cites W2016230247 @default.
- W2895480687 cites W2019146724 @default.
- W2895480687 cites W2028171870 @default.
- W2895480687 cites W2032703975 @default.
- W2895480687 cites W2033591831 @default.
- W2895480687 cites W2035543326 @default.
- W2895480687 cites W2038538605 @default.
- W2895480687 cites W2038569516 @default.
- W2895480687 cites W2039234691 @default.
- W2895480687 cites W2041152829 @default.
- W2895480687 cites W2041356430 @default.
- W2895480687 cites W2046766666 @default.
- W2895480687 cites W2047302854 @default.
- W2895480687 cites W2047463825 @default.
- W2895480687 cites W2047737345 @default.
- W2895480687 cites W2049461277 @default.
- W2895480687 cites W2051293191 @default.
- W2895480687 cites W2054744711 @default.
- W2895480687 cites W2059340669 @default.
- W2895480687 cites W2066242053 @default.
- W2895480687 cites W2079049316 @default.
- W2895480687 cites W2080433813 @default.
- W2895480687 cites W2082740166 @default.
- W2895480687 cites W2084440259 @default.
- W2895480687 cites W2094546718 @default.
- W2895480687 cites W2094613458 @default.
- W2895480687 cites W2097743943 @default.
- W2895480687 cites W2100313064 @default.
- W2895480687 cites W2101584368 @default.
- W2895480687 cites W2107027906 @default.
- W2895480687 cites W2108718836 @default.
- W2895480687 cites W2109150359 @default.
- W2895480687 cites W2111166021 @default.
- W2895480687 cites W2113415973 @default.
- W2895480687 cites W2114276632 @default.
- W2895480687 cites W2117206679 @default.
- W2895480687 cites W2118124054 @default.
- W2895480687 cites W2120174899 @default.
- W2895480687 cites W2124823792 @default.
- W2895480687 cites W2129157579 @default.
- W2895480687 cites W2131587128 @default.
- W2895480687 cites W2132912591 @default.
- W2895480687 cites W2133257334 @default.
- W2895480687 cites W2135288330 @default.
- W2895480687 cites W2136536098 @default.
- W2895480687 cites W2137991845 @default.